Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
PUT
iShares US Oil Equipment & Services ETF
IEZ
$361M
| $57K | ﹤0.01% |
1,600
-79,100
| -98% | -$2.66M |
|
5577
Immersion
IMMR
$251M
| $57K | ﹤0.01% |
8,011
+7,238
| +936% | +$52.4K |
|
5578
CALL
PTC Therapeutics
PTCT
$5.68B
| $57K | ﹤0.01% |
3,400
-146,300
| -98% | -$2.48M |
|
5579
Riverview Bancorp
RVSB
$107M
| $57K | ﹤0.01% |
6,625
+5,422
| +451% | +$48.1K |
|
5580
Seneca Foods Class A
SENEA
$1.12B
| $57K | ﹤0.01% |
1,837
+1,674
| +1,027% | +$55.5K |
|
5581
CALL
ProShares Ultra Russell2000
UWM
$233M
| $57K | ﹤0.01% |
1,600
-600
| -27% | -$20.5K |
|
|
MDC
5582
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
| $57K | ﹤0.01% |
2,095
-3,448
| -62% | -$95K |
|
|
LORL
5583
CALL
DELISTED
Loral Space and Communications, Inc.
LORL
| $57K | ﹤0.01% |
1,300
+600
| +86% | +$28.1K |
|
|
HIVE
5584
DELISTED
Aerohive Networks
HIVE
| $57K | ﹤0.01% |
9,730
+8,989
| +1,213% | +$43.3K |
|
5585
American Superconductor
AMSC
$1.42B
| $56K | ﹤0.01% |
15,440
+5,932
| +62% | +$22.6K |
|
5586
CALL
BGC Group
BGC
$5.45B
| $56K | ﹤0.01% |
5,754
+4,976
| +640% | +$50.2K |
|
|
CRESY
5587
Cresud
CRESY
$795M
| $56K | ﹤0.01% |
2,814
-8,573
| -75% | -$160K |
|
|
DX
5588
Dynex Capital
DX
$3.15B
| $56K | ﹤0.01% |
2,653
+2,297
| +645% | +$49.2K |
|
5589
CALL
Ingredion
INGR
$6.27B
| $56K | ﹤0.01% |
400
+300
| +300% | +$39.6K |
|
5590
Lifecore Biomedical
LFCR
$166M
| $56K | ﹤0.01% |
4,433
+3,011
| +212% | +$38.1K |
|
5591
PUT
Medifast
MED
$109M
| $56K | ﹤0.01% |
+800
| New | +$53.1K |
|
5592
Vishay Precision Group
VPG
$1.22B
| $56K | ﹤0.01% |
2,265
-1,212
| -35% | -$30.7K |
|
|
SAFM
5593
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $56K | ﹤0.01% |
400
-100
| -20% | -$15.4K |
|
|
OXFD
5594
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $56K | ﹤0.01% |
4,016
+3,492
| +666% | +$51.2K |
|
|
FSCT
5595
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $56K | ﹤0.01% |
+1,747
| New | +$46.8K |
|
|
DEST
5596
DELISTED
Destination Maternity Corporation
DEST
| $56K | ﹤0.01% |
18,800
+18,746
| +34,715% | +$47.2K |
|
|
WIN
5597
PUT
DELISTED
Windstream Holdings Inc
WIN
| $56K | ﹤0.01% |
6,060
-7,420
| -55% | -$76K |
|
5598
CALL
ATN International
ATNI
$366M
| $55K | ﹤0.01% |
+1,000
| New | +$54.7K |
|
5599
PUT
Chemours
CC
$2.5B
| $55K | ﹤0.01% |
1,100
-4,800
| -81% | -$251K |
|
5600
PUT
Forestar Group
FOR
$1.44B
| $55K | ﹤0.01% |
2,500
-39,700
| -94% | -$772K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.